AC Immune ACIU
NASDAQ ACIU
$2.60 -0.01 (-0.38%)
At close: Sep 29, 2026 · 4:00 PM EDT

AC Immune (ACIU) Receivables - Accured (2014 - 2026)

Updated

AC Immune's Receivables - Accured was $264,435 in the quarter ended Jun 30, 2026, down 57.1% from $616,024 a year earlier and down 10.0% from the prior quarter.

Analysis

AC Immune (ACIU) Receivables - Accured (2014 - 2026) Analysis & Trends

As of Dec 31, 2025, Receivables - Accured at AC Immune came in at $434,206, down 65.2% from the prior year.

  • Receivables - Accured shows a five-year compound annual growth rate of -23.9% (years ended Dec 2020 to Dec 2025).
  • In earlier years, Receivables - Accured was $1.25 million in the year ended Dec 31, 2024 (+356.1%), $273,907 in the year ended Dec 31, 2023 (-36.0%), $427,700 in the year ended Dec 31, 2022 (-59.9%) and $1.07 million in the year ended Dec 31, 2021 (-37.1%).
  • The figure for the quarter ended Jun 30, 2026 marks the lowest quarterly Receivables - Accured since the quarter ended Mar 31, 2023.
  • Compared with a year earlier, Receivables - Accured has declined for four straight quarters, with growth averaging 68.2% over the last eight quarters.
  • The best year-over-year quarter for Receivables - Accured over five years was the quarter ended Sep 30, 2023 (growth of 582.3%); the worst was the quarter ended Mar 31, 2026 (a decline of 71.5%).
  • Per Business Quant data, ACIU's Receivables - Accured in the three quarters before the quarter ended Jun 30, 2026 was $293,711 (quarter ended Mar 31, 2026), $450,421 (quarter ended Dec 31, 2025) and $502,544 (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables - Accured (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn -
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn -
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 AC Immune 265.55 Mn 265.55 Mn - 264,434.97
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 264,434.97
Mar 31, 2026 293,711.08
Dec 31, 2025 450,421.13
Sep 30, 2025 502,544.02
Jun 30, 2025 616,024.02
Mar 31, 2025 1.03 Mn
Dec 31, 2024 1.25 Mn
Sep 30, 2024 900,281.65
Jun 30, 2024 444,528.98
Mar 31, 2024 305,897.18
Dec 31, 2023 277,329.20
Sep 30, 2023 353,231.60
Jun 30, 2023 750,718.50
Mar 31, 2023 235,693.44
Dec 31, 2022 423,512.94
Sep 30, 2022 51,772.83
Jun 30, 2022 449,580.87
Mar 31, 2022 164,586.87
Dec 31, 2021 1.06 Mn
Dec 31, 2020 1.76 Mn
API Access

AC Immune Receivables - Accured API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-accured&ticker=ACIU&period=max&api_key=YOUR_API_KEY